EPIGENETIC EFFECTS OF THE METHYLATING AGENT 5‐(3‐METHYL‐1‐TRIAZENO) IMIDAZOLE‐4‐CARBOXAMIDE IN HUMAN MELANOMA CELLS
- 1 October 1984
- journal article
- research article
- Published by Wiley in Immunology & Cell Biology
- Vol. 62 (5) , 597-606
- https://doi.org/10.1038/icb.1984.57
Abstract
The anti-tumour methylating agent 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) increased the thymidine and deoxycytidine pools but not the deoxyguanosine pool in human melanoma cells. Incorporation of deoxyguanosine and deoxyadenosine was strongly inhibited by MTIC due to formation of the decomposition product 5-aminoimidazole-4-carboxamide (AIC). Theophylline, natural nucleosides and sulphydryl compounds did not affect the toxicity of MTIC in either MTIC-sensitive (Mer-) or autologous-resistant (Mer+) melanoma cells. 3-Aminobenzamide (3 mM for 48 h), an inhibitor of ADP-ribosyl transferase, greatly enhanced MTIC toxicity in the resistant compared with the sensitive cell line.Keywords
This publication has 3 references indexed in Scilit:
- PROPERTIES OF HUMAN-MELANOMA CELLS RESISTANT TO 5-(3',3'-DIMETHYL-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE AND OTHER METHYLATING AGENTS1982
- REDUCTION OF NICOTINAMIDE ADENINE-DINUCLEOTIDE LEVELS BY ULTIMATE CARCINOGENS IN HUMAN-LYMPHOCYTES1980
- EFFECTS OF 5-(3,3-DIMETHYL-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE AND ITS METABOLITES ON NOVIKOFF HEPATOMA-CELLS1976